1955 Capital

Nature's Fynd is a Chicago-based food company creating a versatile alternative protein to nourish the world’s growing population while nurturing the planet. They produce a range of products using Fy™, a nutritional fungi protein derived from a microbe found in Yellowstone National Park.

Pioneering the next generation in medical robotics, Noah Medical focuses on delivering medical robotic solutions designed to enable earlier diagnosis with greater confidence, particularly in the field of interventional pulmonology.

Gridtential Energy, Inc is pioneering Silicon Joule technology, transforming conventional lead batteries into high-performance, lightweight, and safer energy storage solutions. Their innovative approach allows for the mass production of batteries in existing factories, addressing the urgent need for renewable energy storage.

Crop Enhancement is creating a new class of safe and sustainable pest control products for growers that eliminate or reduce the need for pesticides.

VitalBio is a company transforming diagnostics to improve healthcare access and outcomes. It focuses on innovative technology and aims to prevent disease and reduce health inequality.

Acuamark Diagnostics develops technology that allows for highly accurate screening of blood to detect cancer markers at the early cancer stages, before cancer becomes untreatable.

Inficold is a leading refrigeration/cold chain company that designs and manufactures cold storages, milk coolers, PCM packs/pouches and air conditioners. They utilize thermal energy storage to provide efficient cooling solutions integrated with solar energy.

Craif focuses on the research and development of next-generation diagnostic technologies, particularly for early detection and personalized medicine for cancer and other diseases. Their flagship product, miSignal®, is a non-invasive cancer risk testing service based on urinary microRNA analysis.

Early-stage investor in advanced tech and healthcare that funds companies with at least one female founder, focusing on STEM startups with female executives.

Invests in disruptive, technology-focused startups; established in 1999.

Early-stage investor allocating around 80% to breakthrough climate technologies (carbon-negative concrete, atmospheric carbon removal), acting as a first believer through a venture-and-philanthropy platform backed by the Fukutake family.

Early-stage, first-money-in partner for technically ambitious founders transforming the physical world (energy, defense, infrastructure, space, advanced manufacturing), underwriting high technical and regulatory risk.

Refactor Capital is a solo GP venture fund where founders get direct access to Zal Bilimoria as the only decision-maker, applying software operator experience from Google, Netflix, and LinkedIn to hard tech sectors like aerospace, synthetic biology, and energy storage. The fund leads seed rounds with $1-2M checks targeting ~10% ownership across unusually broad hard-tech domains, backed by early hits like Solugen and Astranis.